Nociception Level-guided Remifentanil Dosing in Children During General Anesthesia - Trial NCT05725382
Access comprehensive clinical trial information for NCT05725382 through Pure Global AI's free database. This phase not specified trial is sponsored by Pia Jaeger, MD, PhD and is currently Not yet recruiting. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 264 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
The NOL monitor (Pain Monitoring Device monitor-PMD200™)
Interventional
device
Sponsor & Location
Pia Jaeger, MD, PhD
Rigshospitalet, Denmark
Timeline & Enrollment
N/A
Feb 06, 2023
Nov 01, 2025
Primary Outcome
First pain score assessed at the PACU
Summary
The investigators aim to investigate whether administration of a short-acting opioid
 (remifentanil) guided by a pain monitor (nociceptive level monitor) during anesthesia, can
 reduce pain in children after surgery.
 
 The investigators hypothesize that pain monitor-guided administration of remifentanil can
 reduce pain postoperatively compared with standard care.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05725382
Device Trial